NANOVIRICIDES, INC. Fair Value Adjustment of Warrants
NANOVIRICIDES, INC. (NNVC) reported Fair Value Adjustment of Warrants of $2.44 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-06-22.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2021-10-12
- NANOVIRICIDES, INC. fair value adjustment of warrants for the quarter ending 2020-03-31 was $2.44K.
- NANOVIRICIDES, INC. fair value adjustment of warrants for the quarter ending 2019-12-31 was $533.00.
- NANOVIRICIDES, INC. fair value adjustment of warrants for the quarter ending 2018-06-30 was -$14.38K.
- NANOVIRICIDES, INC. fair value adjustment of warrants for the quarter ending 2018-03-31 was $4.21K.
- NANOVIRICIDES, INC. fair value adjustment of warrants for fiscal 2018 was $0.00.
- NANOVIRICIDES, INC. fair value adjustment of warrants for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- NANOVIRICIDES, INC. fair value adjustment of warrants for fiscal 2016 was $56.12K.
- NANOVIRICIDES, INC. fair value adjustment of warrants for fiscal 2015 was $0.00.
| Period end | Fair Value Adjustment of Warrants | Fair Value Adjustment of Warrants as first filed | Fair Value Adjustment of Warrants 0 month | Fair Value Adjustment of Warrants 1 month | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | $2.44K 10-Q · filed 2020-06-22 | $2.98K derived: sum of 2 quarters · filed 2020-06-22 | $3.88K 10-Q · filed 2020-06-22 | |||||
| 2020-01-27 | $5.72M 10-K · filed 2021-10-12 | |||||||
| 2020-01-24 | $8.40M 10-K · filed 2021-10-12 | $5.72M 10-K · filed 2020-10-13 | ||||||
| 2019-12-31 | $533.00 10-Q · filed 2020-02-14 | $1.44K 10-Q · filed 2020-02-14 | ||||||
| 2019-02-27 | $7.79M 10-K · filed 2021-10-12 | |||||||
| 2018-06-30 | -$14.38K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-12 | -$10.18K derived: sum of 2 quarters · filed 2018-10-12 | -$5.77K derived: sum of 3 quarters · filed 2018-10-12 | $0.00 10-K · filed 2018-10-12 | ||||
| 2018-03-31 | $4.21K 10-Q · filed 2018-05-21 | $8.61K derived: sum of 2 quarters · filed 2018-05-21 | $14.38K 10-Q · filed 2018-05-21 | $14.38K derived: sum of 4 quarters · filed 2018-10-12 | ||||
| 2017-12-31 | $4.40K 10-Q · filed 2018-02-20 | $10.18K derived: sum of 2 quarters · filed 2018-10-12 | $10.18K derived: sum of 3 quarters · filed 2018-10-12 | -$16.97K derived: sum of 4 quarters · filed 2018-10-12 | ||||
| 2017-09-30 | $5.77K derived: 10-K 12 month − 3 quarters · filed 2018-10-12 | $5.77K derived: sum of 2 quarters · filed 2018-10-12 | -$21.37K derived: sum of 3 quarters · filed 2018-10-12 | -$11.37K derived: sum of 4 quarters · filed 2018-10-12 | ||||
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-12 | -$27.14K derived: sum of 2 quarters · filed 2018-10-12 | -$17.15K derived: sum of 3 quarters · filed 2018-10-12 | $0.00 10-K · filed 2018-10-12 | ||||
| 2017-03-31 | -$27.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | -$17.15K derived: sum of 2 quarters · filed 2017-05-15 | $0.00 10-Q · filed 2017-05-15 | |||||
| 2016-12-31 | $10.00K 10-Q · filed 2017-02-14 | $27.14K 10-Q · filed 2017-02-14 | ||||||
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-12 | $56.12K 10-K · filed 2018-10-12 | ||||||
| 2016-03-31 | $56.12K 10-Q · filed 2017-05-15 | |||||||
| 2015-06-30 | $0.00 10-K · filed 2017-09-28 | |||||||
| 2014-06-30 | $0.00 10-K · filed 2016-09-16 | |||||||
| 2014-03-31 | $7.76M 10-Q · filed 2014-05-15 | $7.76M derived: sum of 2 quarters · filed 2014-05-15 | $11.83M derived: sum of 3 quarters · filed 2014-05-15 | |||||
| 2014-01-24 | $7.76M 10-K · filed 2014-09-30 | |||||||
| 2013-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | $4.07M 10-Q · filed 2014-02-14 | ||||||
| 2013-09-30 | $4.07M 10-Q · filed 2014-05-15 | |||||||
| 2013-09-09 | $5.68M 10-K · filed 2014-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |